Cybersecurity

FDA seeks public input on regulating generative AI medical devices as healthcare enters a new era

26 sec read11 views0 listens

The FDA has launched a public consultation to regulate generative AI in medical devices, aiming to address unique risks not covered by existing frameworks. This initiative is crucial for developers as it outlines evolving regulatory expectations and pathways for market entry while ensuring patient safety. Developers should anticipate continuous monitoring requirements post-approval to adapt to the dynamic nature of AI technologies.

Read the full article at Digital Journal

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Cybersecurity6 hours ago26 sec read

The new frontier of healthcare could be earlier intervention

National health expenditures in the U.S. rose significantly, highlighting the growing importance of prevention and early intervention to improve health outcomes and reduce costs. Digital health technologies are beginning to play a crucial role by pro...

Ali Nemati

Cybersecurity6 hours ago27 sec read

Women's health technology market faces new questions about capacity

The women's health technology sector is experiencing rapid growth, prompting companies to assess whether their infrastructure can support increased demand. This reassessment is crucial as the market expands and consumers become more informed, requiri...

Ali Nemati

Cybersecurity5 days ago27 sec read

AI has plenty of intelligence, but it needs better cognitive infrastructure

Artificial intelligence is expanding into more complex tasks within organizations, yet many are not fundamentally rethinking their operating models to support these advancements. This highlights the need for improved cognitive infrastructure that can...

Ali Nemati